# Astellas Pharma Europe B.V. clinical trials: 94 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 94 trials with Astellas Pharma Europe B.V. as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Astellas Pharma Europe B.V.: 94 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/astellas-pharma-europe-b-v

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 94
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 94, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| February 8, 2021 | NCT04742517 | A Study of MA-0217 (ASP1128) in Healthy Adult Subjects and Healthy Elderly Subjects | Astellas Pharma Europe B.V. | Phase 1 | Completed | Healthy Volunteers | 102 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04742517) |
| October 11, 2018 | NCT03702777 | A Study of ASP8302 in Participants With Underactive Bladder | Astellas Pharma Europe B.V. | Phase 2 | Completed | Underactive Bladder | 135 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03702777) |
| September 13, 2017 | NCT03282318 | A Study to Investigate Efficacy, Safety, Pharmacodynamics and Pharmacokinetics of ASP6294 in the Treatment of Female Subjects With Bladder... | Astellas Pharma Europe B.V. | Phase 2 | Completed | Bladder Pain Syndrome, Interstitial Cystitis | 119 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03282318) |
| April 11, 2017 | NCT03108755 | A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP7713 in Healthy Non-Japanese Adult and Elderly Subjects and Healthy... | Astellas Pharma Europe B.V. | Phase 1 | Completed | Healthy Volunteers | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03108755) |
| November 16, 2016 | NCT02965040 | A Phase 1 Study of Roxadustat in Subjects With Different Degrees of Renal Function | Astellas Pharma Europe B.V. | Phase 1 | Completed | Normal Renal Function, Impaired Renal Function | 34 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02965040) |
| June 9, 2016 | NCT02794792 | A Study to Assess the Efficacy and Safety of Ipragliflozin in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control... | Astellas Pharma Europe B.V. | Phase 3 | Completed | Type 2 Diabetes Mellitus | 268 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02794792) |
| June 2, 2016 | NCT02788123 | A Study To Assess The Efficacy And Safety Of Bismuth Tripotassium Dicitrate (De-Nol) In Combination With Pantoprazole And Pantoprazole... | Astellas Pharma Europe B.V. | Phase 4 | Terminated | NSAID-induced Gastropathy | 9 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02788123) |
| April 26, 2016 | NCT02751931 | Open-label Phase 3 Study With Mirabegron in Children From 3 to Less Than 18 Years of Age With Neurogenic Detrusor Overactivity | Astellas Pharma Europe B.V. | Phase 3 | Completed | Neurogenic Detrusor Overactivity | 91 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02751931) |
| February 15, 2016 | NCT02681861 | A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP6294 Administered Intravenously or Subcutaneously... | Astellas Pharma Europe B.V. | Phase 1 | Completed | Healthy Subjects, Pharmacokinetics of ASP6294 | 74 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02681861) |
| December 18, 2015 | NCT02634489 | EC905 Pharmacokinetic Profile Study | Astellas Pharma Europe B.V. | Phase 1 | Completed | Phase 1, Healthy, Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms | 46 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02634489) |
| November 20, 2015 | NCT02611466 | A Study to Assess the Analgesic Efficacy of ASP7962 in Patients With Pain Due to Osteoarthritis of the Knee | Astellas Pharma Europe B.V. | Phase 2 | Completed | Osteoarthritis of the Knee, Chronic Lower Back Pain | 215 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02611466) |
| August 18, 2015 | NCT02526979 | A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Mirabegron Oral Suspension in Pediatric Subjects From 3 to Less Than... | Astellas Pharma Europe B.V. | Phase 1 | Completed | Overactive Bladder, Neurogenic Detrusor Overactivity | 9 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02526979) |
| May 18, 2015 | NCT02447315 | A Study to Investigate the Effect of Oral Doses of Pilocarpine on Salivary Secretion and Static Pupillometry in Healthy Subjects | Astellas Pharma Europe B.V. | Phase 1 | Completed | Healthy Subjects | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02447315) |
| April 20, 2015 | NCT02420782 | First-in-human: Single Ascending Dose, Food Effect, Drug-drug Interaction, Multiple Ascending Dose, Proof of Pharmacology | Astellas Pharma Europe B.V. | Phase 1 | Completed | Healthy Volunteers | 116 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02420782) |
| February 23, 2015 | NCT02368912 | A Study to Assess the Safety, Tolerability and Effects of Single and Multiple Ascending Doses of ASP1707 in Healthy Male and Pre-menopausal... | Astellas Pharma Europe B.V. | Phase 1 | Completed | Pharmacokinetics of ASP1707, Pharmacodynamics of ASP1707 | 176 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02368912) |
| February 9, 2015 | NCT02359032 | A Combined Single and Multiple Ascending Dose Study of ASP6858 in Healthy Subjects | Astellas Pharma Europe B.V. | Phase 1 | Completed | Healthy Volunteers | 88 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02359032) |
| February 6, 2015 | NCT02358096 | A Study to Evaluate ASP8232 as Add-On Therapy to Angiotensin Converting Enzyme Inhibitor (ACEi) or Angiotensin Receptor Blocker (ARB) in... | Astellas Pharma Europe B.V. | Phase 2 | Completed | Chronic Kidney Disease, Type 2 Diabetes | 125 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02358096) |
| December 11, 2014 | NCT02314793 | A Study to Assess the Safety, Tolerability and Pharmacokinetics of ASP2205 in Healthy Young Males and Females and Elderly Females and to... | Astellas Pharma Europe B.V. | Phase 1 | Terminated | Healthy Subjects, Pharmacokinetics of ASP2205 | 93 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02314793) |
| November 26, 2014 | NCT02302079 | A Study to Evaluate ASP8232 in Reducing Central Retinal Thickness in Subjects With Diabetic Macular Edema (DME) | Astellas Pharma Europe B.V. | Phase 2 | Completed | Diabetes Mellitus, Diabetic Macular Edema | 96 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02302079) |
| November 7, 2014 | NCT02285465 | A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP3700 in Healthy Subjects | Astellas Pharma Europe B.V. | Phase 1 | Withdrawn | Healthy Volunteers, Pharmacokinetics of ASP3700 | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02285465) |
| October 30, 2014 | NCT02278341 | Roxadustat in the Treatment of Anemia in End Stage Renal Disease (ESRD) Patients on Stable Dialysis | Astellas Pharma Europe B.V. | Phase 3 | Completed | Anemia, End Stage Renal Disease (ESRD) | 838 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02278341) |
| September 30, 2014 | NCT02252731 | A Study to Evaluate the Effects of Multiple Doses of FG-4592 on the Exposure, Safety and Tolerability and Effect of Warfarin in Healthy... | Astellas Pharma Europe B.V. | Phase 1 | Completed | Pharmacokinetics of FG-4592, Healthy Subjects | 22 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02252731) |
| September 18, 2014 | NCT02243657 | A Study to Assess the Safety, Tolerability, and Effects in and on the Body of Healthy Young and Elderly Male and Female Subjects of... | Astellas Pharma Europe B.V. | Phase 1 | Completed | Healthy Subjects, Pharmacokinetics of ASP3652, Pharmacodynamics of ASP3652 | 101 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02243657) |
| August 26, 2014 | NCT02225093 | A Study to Evaluate How Daily Dosing With Enzalutamide Affects the Metabolism of Caffeine and Dextromethorphan in Men With Prostate Cancer | Astellas Pharma Europe B.V. | Phase 1 | Completed | Pharmacokinetics of Dextromethorphan, Pharmacokinetics of Caffeine, Prostate Cancer | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02225093) |
| August 20, 2014 | NCT02220777 | A Study to Assess the Effects of Single Ascending Doses (SAD) of ASP8477, the Effect That Food Has on the Drug, and the Interaction Between... | Astellas Pharma Europe B.V. | Phase 1 | Completed | Pharmacokinetics of ASP8477, Pharmacodynamics of ASP8477 | 72 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02220777) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 55 |
| Phase 1/2 | 1 |
| Phase 2 | 12 |
| Phase 2/3 | 1 |
| Phase 3 | 14 |
| Phase 4 | 3 |
| Observational | 8 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 89 |
| Terminated | 4 |
| Withdrawn | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Urinary Bladder, Overactive | 9 |
| Prostatic Neoplasms | 5 |
| Urinary Incontinence | 5 |
| Renal Insufficiency, Chronic | 5 |
| Diabetes Mellitus, Type 2 | 4 |
| Prostatic Hyperplasia | 3 |
| Lower Urinary Tract Symptoms | 3 |
| Anemia | 3 |
| Urologic Diseases | 2 |
| Urinary Bladder Diseases | 2 |
| Diabetes Mellitus | 2 |
| Nocturia | 2 |
| Cystitis, Interstitial | 2 |
| Pain | 2 |
| Urological Manifestations | 1 |
| Signs and Symptoms | 1 |
| Urinary Bladder, Underactive | 1 |
| Endometriosis | 1 |
| Pelvic Pain | 1 |
| Coitus | 1 |
| Urinary Bladder Neck Obstruction | 1 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 |
| Dermatitis, Atopic | 1 |
| Renal Insufficiency | 1 |
| Lymphoma, Non-Hodgkin | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Vehicle manufacturers in the United States](https://specstream.ai/data/businesses/vehicle-manufacturers/united-states)
- [Acupuncture clinics in the United States](https://specstream.ai/data/businesses/acupuncture-clinics/united-states)
- [Avionics shops in the United States](https://specstream.ai/data/businesses/avionics-shops/united-states)
- [Barbecue restaurants in the United States](https://specstream.ai/data/businesses/barbecue-restaurants/united-states)
- [Cafeterias in the United States](https://specstream.ai/data/businesses/cafeterias/united-states)
- [Commercial refrigeration companies in the United States](https://specstream.ai/data/businesses/commercial-refrigeration-companies/united-states)
